Calliditas Therapeutics Suisse SA

Swiss Biotech Association

Member

Calliditas is a commercial stage biopharmaceutical company focused on novel treatments in orphan indications, with an initial focus on renal and hepatic diseases with significant unmet medical needs. In 2021, Calliditas acquired Genkyotex, specializing company in NOX therapies, French & Swiss based.

Location

16, Chemin des Aulx, 1228 Plan-les-Ouates, Switzerland

Get Directions

Facts & figures

Type of organization

Public company
Year of foundation

2004
Number of employees in Switzerland

1-9

Key business

Core competencies

Therapeutics/vaccines (human)

You may also be interested in

CELLnTEC Advanced Cell Systems

CELLnTEC technologies enable science and industry to develop innovations in stem cell research, regenerative medicine, cell-based therapies, and beyond. The company is a pioneering developer of chemically defined, animal and human components-free precision media.
3014 Bern

Member

Caland SA

Caland SA provides a professional, confidential, competitive and impeccable service of pharma-grade CO2 extraction, distillation and cannabis formulation based on GMP requirements.
A modern production line, coupled to a qualified ERP, ensures uncompromising quality of all products and services.
2800 Delémont

Member

Curare Swiss AG

Curare provides strategic advice to assist in the successful design of R&D programs. From the non-clinical to clinical Proof-of-Concept. The right decisions at the right time. Curare's experts put their years of experience and knowledge relating to translational and clinical drug development to use.
4056 Basel

Member